Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	27.80B
Revenue (ttm)	13.93B
Net Income (ttm)	2.20B
Shares Out	4.57B
EPS (ttm)	0.48
PE Ratio	12.72
Forward PE	11.31
Dividend	0.23 (3.92%)
Ex-Dividend Date	Jun 2, 2025

Volume	1,844,549
Average Volume	9,589,320
Open	5.95
Previous Close	6.09
Day's Range	6.01 - 6.33
52-Week Range	3.60 - 6.54
Beta	0.50
RSI	66.76
Earnings Date	Aug 28, 2025

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The Medical Device Products segment includes safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions. The Orthopedic Products c...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1988
• Employees: 12,719
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY